chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BAD CHILLS; MUSCLE PAIN; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced bad chills, and muscle pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the bad chills and muscle pain was not reported. This report was non-serious.
chills fluctuating in temp, body aches and joints, 101.2 fever, loss of appetite, chest pains
Arm and started an hour after shot Pain worsened and spread to entire arm, back, neck 12 hours after injection Axillary pain and lymphadenopathy started 24-36 hours later on same arm
pt recvd vax;local rxn, consisting of redness,swelling,warmth,tenderness of about  1 1/2" w/ central bluish ctr; low grade fever & fussiness;
During the night following the vaccination, I collapsed feeling sick and very dizzy.  I could not get up off the floor where I had fallen and the paramedics had to be called by my wife.  They arrived and found me on the floor in the ensuite bathroom.  They could not get me up off the floor.  Eventually taken to A&E due to falling blood pressure and general state of dizziness and sickness.  Finally diagnosed with Vestibular Neuritis.
The initial case was missing the following minimum criteria: unidentifiable patient. Upon receipt of follow-up information on 27Apr2015, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable consumer who reported similar events for two patients. This is the first of two reports. A female patient of an unspecified age and ethnicity received PREVNAR 13 (Lot # 31687, expiration date and NDC number unknown), via an unspecified route of administration on an unspecified date at single dose. Medical history and concomitant medications were not reported. The patient was administered a vaccine that had an issue and got staph infection at the injection site on an unspecified date. The outcome of the events was unknown. The reporter mentioned that she wanted information regarding safety and quality of this vaccine which they could extend to the patient and she wanted some information to ensure that this vaccine was unable to contain live staph infection.
11Apr90 pt vax;  06Aug90 tests revealed immunity for rubella, but not measles & mumps.
A few seconds after vaccine administration the patient had a series of short convulsions that caused loss of consciousness for a few seconds. The patient regained awareness seconds after the convulsions, but complained of headache, weakness, and tiredness. The patient was alert and oriented after initially fainting. The parents stated he had travelled for 12 hours straight, and had not adequately hydrated or eaten well. The patient appeared pale in appearance and vomited after drinking water and soda pop. The vomitus was clear and only a small amount, after which the patient felt better. The patient was observed for 45 minutes prior to leaving  for their departing flight. The parents stated that vaccination anxiety, hunger, and dehydration may have played a role in this episode.
Within five minutes of receiving injection, I had a metallic taste at the back of my throat, my tongue was burning my lips were numb, and my fingers and toes were ice cold
Patient stated after vaccination felt lightheaded and numbness on left side. She sat down and had her blood pressure taken. It was 171/105. Stated that she had not taken her morning blood pressure medications (lisinopril 10mg and atenolol 50mg). The nurse at the facility gave her a dose of lisinopril 10mg. Patient then stated prickly, numb feeling and foggy-headed. The facility then gave her 2 doses of diphenhydramine 25mg. At approximately 11am, patient was still not improving and felt like she was getting worse. The facility then called for an ambulance to take her to the ER for assessment.
Didn't notice anything until over 24 hours after the shot. Swelling in a oval shape, at first about 2x3 inches, some redness at the center of the swelling. Swelling is hot. Treated with 50mg Benadryl every 6 hours, and ice on the swelling. (Also taking naproxen.) Continued to swell. Tender to the touch, becoming more tender. On 3/18/2013 it is about 3"x4" (it was larger on 3/17/2013). Have abdominal pain and diarrhea. Planning to start prednisone later today, waiting 12 hours after the last naproxen.
Injection point very sore.  Cannot lift arm.  Upper arm (shoulder to elbow) red in color and sensitive to touch.  High temperature, 101.8 F.  Night sweats.  Following day temperature subsides to low grade, 99.3 F.
Around 5pm, seven hours after getting the shot, I got all body chills, pain, weakness, cold hands and feet. A fever began at 7pm.
Patient c/o itchy all over.. First injection site and then all over. Red: Vitals 132/86, O2 99, P66, R 13/ No c/o shortness of breath or any other issue. Given Benadryl at 920am. At 945 feeling better.
Tested COVID-19 positive, resulted in hospital admission. Symptoms include chills, cough, and shortness of breath.
3 hrs after vaccination, patient reports feeling dizzy. This dizziness lasted 2 days. Patient reports that she was needing help caring for her newborn, because she was needing to mostly just lie down.   Patient reported these symptoms before receiving her second dose of the Pfizer vaccine 30145BA and was instructed to "drink lots of water" in the coming hours after vaccination. After her second dose, the patient waited a full 30 minutes because of her Baclofen allergy; no incidents occured.
Patient developed pneumonia during the first week of June in 2019; This spontaneous report as received from pharmacist via company representative refers to an 85-year-old male patient. The patient's concurrent conditions included colon cancer.The patient was allergic to lidocaine. Historical vaccine included pneumococcal 13v conj vaccine (PREVNAR 13) on an unspecified date in 2014. The patient's concomitant medication was not reported.     On an unspecified date in 2018, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX 23) (strength, dose, route, frequency, lot # and expiry date were not reported) for immunisation. On an unknown date in June 2019 (reported as "during the 1st week of June in 2019"), the patient experienced pneumonia. The patient was admitted to an unspecified hospital for one week and received unspecified treatment. It was unknown whether any lab diagnostics/studies were performed. The patient sought medical attention. The outcome of pneumonia was reported as recovered. The causality assesement was not provided by the reporter. No product quality complaint was reported.         Upon internal review, the event pneumonia was determined to be medically significant.
Systemic cutaneous reaction with erythema and urticaria. No wheezing. No upper respiratory distress.
I was unable to breathe after the 2nd dose. I was taken to urgent care and then to Hospital. They did a chest Xray because they suspected COPD. It was determined I do not. I was given oxygen. My heart rate was 120, bp was 240/140, sats was 83. I was given a breathing treatment and oxygen. A COVID test was done and came back negative. I then saw a pulmonologist. I was put on breathing treatments as well. I saw an ENT who put me on steroids and antibiotics. I started feeling better then. I had some relapses after ending the steroids. I ended up in the ER 3 more times after that. I have been staying on the steroids since then but gradually weaning off. I am now down to 10/day (5/morning, 5/night. Since the sinus surgery, I seem to be getting better.  I have less congestion and my breathing is better. I feel that I am definitely getting better.
diaphoretic; light-headed; nausea; hadn't eaten all day; BP initially low at 85/53; hypotensive; hypoglycemic; This is a spontaneous report from a contactable physician (reported for patient). A 29-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EM9810, Expiration date was not reported), dose 1 intramuscular, administered in Arm Left on 27Feb2021 14:07 (age at vaccination 29 years) as dose 1, single for covid-19 immunisation. The patient Medical history was none. There were no concomitant medications. No Prescription over the counter medication, dietary supplements, or herbal remedies being taken at the time of vaccination. Patient had no allergies to medication, food or other products, no Other illness at the time of vaccination and up to one month prior, also not Chronic or long-standing health conditions. Patient visited Doctor or other healthcare professional office/clinic visit. On 27Feb2021 14:17 the patient experienced diaphoretic, light-headed, nausea, hadn't eaten all day, bp initially low at 85/53 which improved upon lying down, hypotensive, hypoglycemic event most likely unrelated to vaccine. Patient discharged to home in stable condition after observation over 30 minutes. The patient underwent lab tests and procedures which included blood pressure measurement was 85/53 on low, blood pressure measurement was 110/70 (normalized), vital signs measurement was stable. Therapeutic measures were taken as a result of bp initially low at 85/53 given water as treatment. On an unspecified date in 2021, the patient had recovered from the events.  No follow-up attempts are possible. No further information is expected.
Information has been received from a nurse practioner referring to six unspecified patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (strength, lot#, route and dose were unknown). No adverse events were reported. Additional information has been requested.
Injection site is painful, red, and swelling. I have a headache, feel very tired, have muscle aches, am nauseated, have fever, and have dizziness and weakness.
Saturday-- Day of vaccination--odd feeling in evening, Sunday--fatigue, continuing odd feeling, Monday--dizziness, headache, fatigue. Following weeks--usually dizziness, headaches off and on, fatigue often.  Symptoms vary from day to day in severity.  Feels like a concussion that doesn't go away.
Immediate and excruciating pain upon administration of tetanus shot 10/13/12 1:15 PM. Inability to raise arm without extreme pain for over 2 weeks. Pain at site of injection has continued as well as radiating pain into shoulder area for one year. X-ray and MRI's done - rotator cuff shows small tear. Physical therapy 3x a week from 4/22/13 thru 7/11/13 with no improvement. Cortisone shot 2x provided only short temp. relief. One year after inoculation - inability to raise arm, sleep, drive, change clothes, or do any physical activity without pain.
Wrong technique in device usage process; This spontaneous case was reported by a consumer and describes the occurrence of WRONG TECHNIQUE IN DEVICE USAGE PROCESS (Wrong technique in device usage process) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042620A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced WRONG TECHNIQUE IN DEVICE USAGE PROCESS (Wrong technique in device usage process). At the time of the report, WRONG TECHNIQUE IN DEVICE USAGE PROCESS (Wrong technique in device usage process) outcome was unknown.            Patient is overweight. Concomitant information was not reported. Treatment information was not reported. The action taken with mRNA-1273 with the event was considered as not applicable.    This case was linked to MOD-2021-231771 (Patient Link).
Narrative:  COVID infection following completion of COVID vaccine series 01/25 COVID Vaccine dose #1 02/16 COVID vaccine dose #2 04/18 Admitted to outside hospital c/o SOB and weakness, o2 sat 92% on RA, tachypneic and in afib with RVR upon arrival to ED; CXR showed diffuse infiltrates. COVID test was positive; HR improved after fluid bolus; started on remdesivir and dexamethasone through 4/22 04/22 discharged from outside hospital on home oxygen 04/27 Only persistent symptom is intermittent cough
Patient received Moderna formulation for 12+years old. Child is 10 years old.
Pt had tingling/burning sensation in arm at injection site, egg size lump in arm, blurred vision, profuse sweating, vomiting, hives.  Through the night had shortness of breath. Pt was given Kenalog injection and Benadryl by mouth
Headache, nausea, sweating,  hot & cold at the same time, vomiting
Heart rate increased hours later, heart rate stayed elevated through the night while I was sleeping. My tracker showed it not going below 90 and was as high as 129. I have never experienced an issue with my heart. My heart rate did decrease back to normal by the afternoon.  Also had experience chills fatigue that night and headache the next morning.
Mom called day after vaccines given to report redness/pain-advised cold compresses, TYLENOL/MOTRIN, BENADRYL-walking fine but redness extends from hip and knee (left leg) pt came in 7/20/18 per mom area improving but still present. Parent feels like it's an adverse reaction to the HIB. Advised MOTRIN, cool pads if unable to walk or worse come back to the office. Parent ask that we report this.
This is a spontaneous report from a contactable nurse. A 16-year-old male patient received TRUMENBA (lot R94916, expiry date 31Jan2019, NDC number: 0005-0100-10) intramuscular, in left deltoid, on 27Jun2017 at 15:36, at 0.5 ml single, for immunisation. Prior vaccinations (within 4 weeks) were none. The patient medical history was none. The patient had an ongoing allergy to cefprozil (taken from 2013). Concomitant vaccination included MENACTRA (lot U5514AC, expiry date 12Mar2018) intramuscular, in right deltoid, on 27Jun2017, at 0.5 ml single, for immunisation. The patient previously took a dose of MENACTRA in 2011 for immunization. On 27Jun2017 at the injection site there was spreading of redness on the skin which was reported as a non-serious event. Since an unspecified date in Jun2017 it was very painful, very hot to the touch and the patient had limited range of motion in his left arm. These events have been considered medically significant by the reporter who saw the patient on 28Jun2017 and on 29Jun2017 and the redness was kind of big, spreading even worse. They measured the dimensions of the redness on 29Jun2017 morning and it was 5.3 inches in length and 4.2 inches in width. The patient was being treated for localized warmth and limited range of motion. Pain and redness had not yet resolved at the time of report. The other events outcome was unknown. The reporter assessed the events as related to TRUMENBA. Sender's Comments: The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, as appropriate. The case will be reassessed if additional information becomes available.
A report has been received health professional concerning a 12 years old female patient. No information regarding relevant history, concomitant disease and concomitant medications were provided. Patient has been receiving Nasal FLUMIST, which was given on 06-Sep-2012. MedImmune BSS reported that the registered nurse stated that a patient experienced flu like symptoms mid Jan 2013, flu test has not been done. The patient recovered from the event of experienced flu like symptoms on an unspecified date. The reporter considered the event to be non-serious.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (his arm was sore for a few days a little bit more than with the 1st one) and HYPERTENSION (his blood pressure started going up, 160/170/180/ his pressure was 190/90) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 026L20A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included METOPROLOL, AMLODIPINE and SIMVASTATIN for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (his arm was sore for a few days a little bit more than with the 1st one). On 13-Mar-2021, the patient experienced HYPERTENSION (his blood pressure started going up, 160/170/180/ his pressure was 190/90). The patient was treated with LISINOPRIL on 17-Feb-2021 for Blood pressure high, at a dose of 10 mg and LISINOPRIL ongoing from 19-Mar-2021 for Blood pressure high, at a dose of 20 mg. At the time of the report, PAIN IN EXTREMITY (his arm was sore for a few days a little bit more than with the 1st one) and HYPERTENSION (his blood pressure started going up, 160/170/180/ his pressure was 190/90) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Feb-2021, Blood pressure measurement: 160/170/18 (High) high. In February 2021, Blood pressure measurement: 190/90 (High) high. This case was linked to MOD-2021-052646.
Her left arm became severely sore (almost unbearable, she had a high fever that first evening, on 10/19/06 her arm turned red and swelled up. She has been taking Motrin and putting ice on her arm. The swelling, pain and fever have all went away.
COVID-19 positive on rapid antigen test with compatible symptoms; COVID-19 positive on rapid antigen test with compatible symptoms; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (COMIRNATY), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID-19 positive on rapid antigen test with compatible symptoms". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the available information, there is a reasonable possibility of a causal relationship between the suspect vaccine BNT162B2 (COMIRNATY) and reported events drug ineffective and COVID-19 which cannot be fully assessed/excluded. The case will be reassessed if additional information becomes available.
JNJ 1st. Not a single side effect.  Pfizer booster 8 months later threw me for a loop. Fever, chills, nausea for 2 days.
severe pain in lower left side.; diarrhea; diverticulitis; Had black liquid stool.; This is a spontaneous report from a contactable consumer (patient). A 59-year-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6207), via an unspecified route of administration, administered in left arm on 23Mar2021 07:15 as single dose for covid-19 immunization in a pharmacy. Medical history was reported as none. No known allergies. The patient was taking an unspecified antibiotic between 1-2 weeks. No other vaccinations were done in four weeks. The patient has not had COVID-19 prior to vaccination and has not been tested for COVID-19 post vaccination. On 24Mar2021, 1 day after vaccination the patient had diarrhea. On 25Mar2021, 2 days after, the patient had severe pain in lower left side. The patient was diagnosed with diverticulitis on an unspecified date in Mar2021. The patient also reported black liquid stools in Mar2021. The patient ended up in the ER on an unspecified date and got a scan and was sent home with antibiotics as treatment. The patient was getting better but not yet 100%. The patient underwent lab tests and procedures which included scan: unknown results on an unspecified date. The outcome of the events was recovering.
Client received his first dose of the Pfizer Covid-19 Vaccine on 5/5/21 (Lot #EW0167 Exp. 08/2021) and his second dose of the Pfizer Covid-19 Vaccine on 5/26/21 (Lot #EW0185 Exp. 08/2021). Client came in on 6/9/21 at 10:45 AM asking to speak with a nurse about a possible vaccine reaction. Nurse went outside to talk to client. Interpreter was present. Client reported that approximately 48 hours after his second dose of the Pfizer Covid-19 Vaccine, he began noticing small red marks on both arms. The rash was not on any other body part. The client still had the rash on arms today (6/9/21), 15 days after his second vaccine. The client denied any other symptoms. The client also denied being short of breath or having difficulty breathing. Client denied any abnormal side effects from his first dose of the vaccine. The client has no known allergies, denies any prescription medication, and has no significant medical history. The client did not contact a care provider due to lack of insurance. The client also took Benadryl for the rash but stopped because he ?didn?t like the way it made (him) feel?. We discussed the situation with Nurse. Nurse called to find the nearest health center that takes clients without insurance. Nurse then educated client about the need to see a primary care provider, as we cannot give medical advice since we are a vaccination site. Client was provided with phone number and address of Medical Services. Client departed in positive disposition and stated that he was going to ?call and make an appointment? at the health center.
I received the shot on 3/10 at 5pm 3/11 3AM - I woke up from my sleep with chills, body aches, fever, my left arm where I received the injection was twitching. I had to take tylenol to fall back asleep. 9AM - I wake up fatigued with a low fever 12PM - Fever goes up, chills and body aches return. I take tylenol and they go away. 3 PM - Fever goes away completely 3/12 - I wake up and my symptoms are gone
One day post vax the pt developed macropapular scattered areas, scattered around right deltoid area from .5 to 1.5 cm. Diagnosis: allergic reaction. Pt was treated with Allegra